FDA Inspection 1086878 — Andreas H. Diacon, M.D., Ph.D
The FDA completed an inspection of Andreas H. Diacon, M.D., Ph.D on April 5, 2019 in Cape Town. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cape Town (South Africa)
Additional Details
Clinical Investigator (CI)